Clinical Trial: NEUROphysiology of CRACK Use Disorder in ITaly

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07735923) titled 'NEUROphysiology of CRACK Use Disorder in ITaly' on July 23.

Brief Summary: The goal of this randomized clinical trial is to verify if a Scott-Kaiser neurofeedback protocol can improve inhibitory control, reduce craving, and enhance treatment adherence in individuals with crack cocaine use disorder.

The main research question is: does a 30-session, multi-phase neurofeedback intervention lead to better clinical outcomes, resulting in a more significant stabilization of the therapeutic pathway and reduction in relapse and drop-out rates, compared to treatment as usual (TAU) alone?

Participants will:

* Undergo initial assessment (T0)...